Randomized study of intensified anthracycline doses for induction and recombinant interleukin-2 for maintenance in patients with acute myeloid leukemia age 50 to 70 years: results of the ALFA-9801 study - Pautas, C; Merabet, F; Thomas, X (J Clin Oncol, 2010)
et al.